Emicizumab prophylaxis in adolescent/adult patients with hemophilia A previously receiving episodic or prophylactic bypassing agent treatment: updated analyses from the HAVEN 1 study - Mancuso, M E; Callaghan, M U; Kruse-Jarres, R (Blood, 2017)